John McDermott

Executive Director and Head, Drug Development Solutions (EMEA)
Quotient Sciences

John has worked in the pharmaceutical industry for almost 20 years, with industry experience in roles with Rhone Poulenc Rorer, Covance and Quotient Sciences, which he joined in 2001. He has been central to the development of Translational Pharmaceutics®, Quotient’s unique platform which integrates formulation development, real-time manufacturing and clinical testing, to accelerate drug product development. John has a significant body of experience in drug delivery and dosage form development for oral and inhaled drugs, including poor solubility compounds, modified release systems and paediatric drug products.